You are here
Servier Worldwide
- 1st independent French pharmaceutical company.
- Over 20,000 employees.
- Nearly 3000 researchers preparing the drugs of the future.
- All profit is invested in Research and Development.
- 44 new chemical entities currently under development in the following therapeutic fields: cardiovascular diseases, central nervous system and psychiatry, cancer research, diabetes and metabolism, and rheumatology.
- Present in 140 countries over 5 continents. 92% of Servier’s medicines are prescribed internationally.
- A turnover of 3.9 billion euros for 2012.